170842 ⎘
Detection or diagnosis of diseases; Neurological disorders; Dementia; Cognitive disorders Alzheimer
Abeta conformer selective anti-Abeta globulomer monoclonal antibodies
#902Diagnostic drug and diagnostic method for Alzheimer's disease
#903Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#904Assay method for Alzheimer's disease
#905Computer systems for treating diseases
#906Method of providing disease-specific binding molecules and targets
#907Selected reaction monitoring assays
#908Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
#909Transgenic animal expressing Alzheimer's tau protein
#910Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
#911Diagnostic autoantibody profiles for the detection and diagnosis of neurodegenerative diseases
#912Computer systems for treating diseases
#913Regulatory proteins and inhibitors
#914Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease
#915Diagnosis of alzheimer's disease using Aβ22(pE)-42 peptide
#916PHARMACEUTICAL COMPOSITION TO PREVENT AND TREAT ALZHEIMER'S DISEASE COMPRISING GCP II MUTANT
#917Methods of Detecting a Fragment of Neurosecretory Protein VGF for Diagnosing Alzheimer's Disease
#918Antibodies to alpha synuclein
#919METHODS OF USING HUMAN PROTEIN KINASE C DELTA VIII AS A BIOMARKER
#920METHOD FOR DETECTION OF AMYLOID BETA OLIGOMERS IN A FLUID SAMPLE AND USES THEREOF
#921Amyloid Precursor Protein E2 Domain and Uses Thereof
#922METHOD AND APPARATUS FOR REMOVING NOXIOUS MATERIALS FROM CELLS
#923YEAST CELLS EXPRESSING AMYLOID BETA AND USES THEREFOR
#924BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS
#925Method for diagnosing a protein misfolding disease using nerve cells derived from iPS cells
#926Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases
#927BIOMARKERS FOR ALZHEIMER'S DISEASE
#928Antibodies that bind tau oligomers
#929BIOMARKERS FOR NEUROLOGICAL CONDITIONS
#930REGULATION OF BACE DEGRADATION
#931Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#932Methods of detecting oxidized calcium/calmodulin dependent protein kinase II
#933Dynactin subunit p62 biomarker for neurological conditions
#934Glucagon/GLP-1 receptor co-agonists
#935Glucagon/GLP-1 receptor co-agonists
#936Modulation of synaptic maintenance
#937Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
#938FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#939Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
#940SPECIFIC SALIVARY BIOMARKERS FOR RISK DETECTION, EARLY DIAGNOSIS, PROGNOSIS AND MONITORING OF ALZHEIMER'S AND PARKINSON'S DISEASES
#941Diagnostic method for Alzheimer's disease
#942Method for detecting a panel of biomarkers
#943Screening methods for compounds that modulate ARF-6 mediated endosomal redistribution
#944Pharmaceutical composition
#945Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics
#946NEUROTROPHINS AND USES THEREOF
#947DIAGNOSTIC AND TREATMENT METHODS USING A LIGAND LIBRARY
#948Method for binding a recombinant polypeptide to a carrier
#949PREVENTION, TREATMENT AND DIAGNOSIS OF DISEASES ASSOCIATED WITH BETA-AMYLOID FORMATION AND/OR AGGREGATION
#950USE OF CYTOKINE LEVELS IN INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF ALZHEIMER'S DISEASE
#951CELLULAR RESPONSE ASSAY FOR BIOFLUID BIOMARKER DISCOVERY AND DETECTION
#952ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE
#953Diagnostic antibody assay
#954Compounds for binding and imaging amyloid plaques and their use
#955METHOD AND SYSTEM TO DETECT AND DIAGNOSE ALZHEIMER'S DISEASE
#956Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#957Methods of treating diseases
#958BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE
#959Antibody recognizing turn structure in amyloid β
#960APOE immunotherapy
#961MUTANT LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN WITH INCREASED BINDING TO ALZHEIMER AMYLOID-BETA PEPTIDE
#962Agents that reduce neuronal overexcitation
#963Neurodegenerative Markers for Psychiatric Conditions
#964Modulation of synaptic maintenance
#965Inhibitors of the nitration of amyloid β peptides and their uses in the diagnosis and treatment of Alzheimer's disease
#966Amyloid β fibrillogenesis-inhibiting peptide
#967CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
#968Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines
#969MEASUREMENT OF ANTI-AMYLOID ANTIBODIES IN HUMAN BLOOD
#970BIOMARKERS AND METHODS FOR DETECTING ALZHEIMER'S DISEASE
#971Antibodies that specifically bind to a beta oligomers and use thereof
#972OXIDATIVE STRESS MEASUREMENT DEVICE AND RELATED METHODS
#973Anti-ADDL antibodies and uses thereof
#974Polynucleotides encoding an anti-beta-amyloid monoclonal antibody
#975Antibodies that specifically bind to A beta oligomers and use thereof
#976Antibodies that bind amyloid oligomers
#977Methods and compositions for the diagnosis and prognosis of Alzheimer's disease
#978Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereof
#979Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation
#980Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
#981Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders
#982DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#983Screening method
#984Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
#985ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS
#986Serum Diagnostic Method, Biomarker and Kit for Early Detection and Staging of Alzheimer's Disease
#987METHOD FOR DETECTING BETA-AMYLOID USING AMINO ACID DIMERS
#988METHOD FOR SCREENING INHIBITOR FOR INHIBITING INTERACTION BETWEEN BETA-AMYLOID PEPTIDE AND VEGF AND INHIBITOR SEARCHED BY THE SAME
#989KIT AND METHOD FOR THE PREMORTEM IN VITRO DETECTION OF ALZHEIMER'S DISEASE
#990Antibodies that specifically bind to A beta oligomers and use thereof
#991APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER
#992METHODS
#993MITOCHONDRIAL INHIBITORS AND USES THEREOF
#994Diagnostic antibody assay
#995Methods for identifying safe and functional humanized antibodies
#996Innovative blood platelets biomarker for early diagnosis of alzheimer's disease
#997GLYCOPEPTIDE AND USES THEREOF
#998IRAK KINASE FAMILY AS NOVEL TARGET AND BIOMARKER FOR ALZHEIMER
#999Methods and compositions comprising tau oligomers
#1000Methods for Modulating Macrophage Proliferation Using Polyamine Analogs
#1001Markers for brain damage
#1002Biomarkers for diagnosing alzheimer's disease
#1003Naphthalene-based inhibitors of anti-apoptotic proteins
#1004Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers
#1005Methods for measuring concentrations of biomolecules
#1006Binding of aggregated forms of proteins
#1007APOE4 AND APOJ BIOMARKER-BASED PREVENTION AND TREATMENT OF DEMENTIA
#1008SPECTRAL DATA ANALYZER, BIOLOGICAL SUBSTANCE DETECTION SYSTEM, AND BIOLOGICAL SUBSTANCE DETECTION METHOD
#1009Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#1010G PROTEIN-COUPLED RECEPTOR ANTAGONIST AND ITS USE FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE
#1011Compositions and methods for treatment of neurodegenerative diseases
#1012Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
#1013TAU PROTEASE COMPOSITIONS AND METHODS
#1014Diagnostic devices and methods of use
#1015Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
#1016Prevention and Treatment of Amyloidogenic Disease
#1017Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
#1018Human anti-alpha-synuclein antibodies
#1019METHODS OF DETECTING A FRAGMENT OF NEUROSECRETORY PROTEIN VGF FOR DIAGNOSING ALZHEIMER'S DISEASE
#1020SCREENING METHOD
#1021PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1022Monoclonal antibodies against amyloid beta protein and uses thereof
#1023Optical method for detecting Alzheimer's disease by systemic administration of curcumin
#1024AB-REMOVER, AB-REMOVING APPARATUS, AND AB REMOVAL METHOD
#1025ALZHEIMER'S DISEASE BIOMARKERS
#1026Method for early diagnosis of alzheimer'S disease using phototransistor
#1027CAPTURING AND DELIVERING MOLECULES IN A MAMMAL
#1028Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#1029GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#1030Complex of a chaperone with β-amyloid and methods employing this complex
#1031METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS
#1032Method for Detecting Soluble Amyloid Precursor Protein (APP) Alpha and/or Soluble APP Beta
#1033Methods and compositions for eliciting an amyloid-selective immune response
#1034METHOD FOR TESTING ALZHEIMER'S DISEASE BY MEASURING DEGRADATION RATE OF ß-AMYLOID IN BLOOD AND DIAGNOSTIC REAGENT
#1035Diagnosis of Alzheimer's Disease
#1036Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
#1037ABNORMAL ALTERATIONS OF PKC ISOZYMES PROCESSING IN ALZHEIMER'S DISEASE PERIPHERAL CELLS
#1038Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
#1039SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS
#1040Curcumin Derivatives for Amyloid-Beta Plaque Imaging
#1041EVALUATION OF 24S-HYDROXYCHOLESTEROL IN HAIR FOR METABOLIC BIOMARKER OF ALZHEIMER'S DISEASE
#1042New Therapeutic and Diagnostic Methods for Alzheimer's Disease
#1043NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
#1044MONOCLONAL ANTIBODIES SPECIFIC FOR PATHOLOGICAL AMYLOID AGGREGATES COMMON TO AMYLOIDS FORMED FROM PROTEINS OF DIFFERING SEQUENCE
#1045ASSAY FOR PATHOGENIC CONFORMERS
#1046PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1047METHODS FOR THE PREDICTION OF SHORT-TERM AND LONG-TERM COGNITIVE DECLINE IN ALZHEIMER'S DISEASE PATIENTS USING CSF BIOMARKERS
#1048Methods and compositions for the treatment of symptoms of neurological and mental health disorders
#1049Regulation of BACE degradation
#1050PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1051CD44 splice variants in neurodegenerative diseases
#1052Method of treating neurological conditions with cardiac glycoside
#1053Ligands for aggregated tau molecules
#1054NOVEL DIAGNOSTIC METHOD
#1055COMPOSITIONS AND METHODS RELATING TO DETECTION OF SOLUBLE E-CADHERIN IN NEURODEGENERATIVE DISEASE
#1056Methods and compositions for treating alzheimer's disease
#1057METHODS OF DIAGNOSING ALZHEIMER'S DISEASE
#1058METHODS AND KITS FOR DIAGNOSING NEURODEGENERATIVE DISEASE
#1059Anti-ADDL antibodies and uses thereof
#1060DIAGNOSIS AND TREATMENT OF REVERSE CHOLESTEROL TRANSPORT DEFICIENCY-RELATED DISEASES
#1061Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases
#1062GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#1063Isolsted Monoclonal - Associated Protein Tau and Kit
#1064Monoclonal antibodies against GMF-B antigens, and uses therefor
#1065Fibroblast growth patterns for diagnosis of Alzheimer's disease
#1066Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
#1067BIOMARKERS FOR ALZHEIMER'S DISEASE
#1068Diagnostic method for Alzheimer's disease
#1069METHODS, COMPOSITIONS AND COMPOUND ASSAYS FOR INHIBITING AMYLOID-BETA PROTEIN PRODUCTION
#1070COMPOSITIONS AND METHODS FOR DIAGNOSIS, STRATIFICATION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1071SCREENING METHOD FOR AGENTS SUITABLE FOR PROPHYLAXIS AND THERAPY OF ALZHEIMER'S DISEASE (AD)
#1072ABeta-OLIGOMER MEASUREMENT METHOD
#1073BIOMARKERS OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
#1074METHOD OF UPREGULATING SORLA FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#1075BLOOD SERUM MARKER FOR DETECTION AND DIAGNOSIS OF ALZHEIMER'S DISEASE
#1076Methods of determining levels of free amino acids and dipeptides and diagnosing Alzheimer's disease
#1077Antibody Capable of Binding Specifically to AB-Oligomer, and Use Thereof
#1078Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses
#1079Protein Biomarkers for Alzheimer's Disease Detection
#1080NOVEL ASSAY
#1081Method and System to Detect, Diagnose, and Monitor the Progression of Alzheimer's Disease
#1082USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#1083Method for diagnosing alzheimer's disease using serum glycoprotein as biomarker
#1084MEASUREMENT OF PROTEIN KINASE ACTIVITY IN CEREBROSPINAL FLUID FOR DIAGNOSIS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
#1085Method for Examination of Alzheimer's Disease
#1086Diagnostic kit for Alzheimer's disease, diagnostic marker, and detection method for indicator of pathological state thereof
#1087Stable amyloid beta monomers and oligomers
#1088PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#1089Diagnostic screens for Alzheimer's disease
#1090Method for detecting disease markers
#1091SCREENING METHODS FOR AMYLOID BETA MODULATORS
#1092PTPH1 Inhibitors for the Treatment of Alzheimer's Disease
#1093Histidine related compounds for identifying and blocking amyloid beta ion channels
#1094MARKER PEPTIDE FOR ALZHEIMER'S DISEASE
#1095KCNN3 AS DIAGNOSTIC AND THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISEASES
#1096Monoclonal antibody and use thereof
#1097CLASSIFYING AMYLOIDOSIS
#1098AGENT AND METHOD FOR DIAGNOSIS ON THE OCCURRENCE OF ALZHEIMER'S DISEASE OR THE TENDENCY TO DEVELOP ALZHEIMER'S DISEASE
#1099Immunological targeting of pathological Tau proteins
#1100Diagnosis of parkinson's disease
#1101BINDING OF PATHOLOGICAL FORMS OF PROTEINS USING CONJUGATED POLYELECTROLYTES
#1102BINDING OF PATHOLOGICAL FORMS OF PROTEINS USING CONJUGATED POLYELECTROLYTES
#1103SIGNALING INTERMEDIATES IN AN IN VITRO MODEL OF ALZHEIMER'S DISEASE
#1104Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
#1105Antibody and use thereof
#1106COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITY
#1107SCREENING METHOD FOR AGENTS SUITABLE FOR THERAPY OF ALZHEIMER'S DISEASE
#1108CYCLOPHILIN D-AMYLOID BETA INTERACTION POTENTIATES MITOCHONDRIAL DYSFUNCTION IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE
#1109Antibody Specific Binding to A-Beta Oligomer and the Use
#1110HUMAN FG01 GENE AND ITS APPLICATIONS
#1111MEMORY AND LEARNING IMPAIRMENTS ASSOCIATED WITH DISRUPTION OF EPHRIN RECEPTOR A6 (EphA6) GENE
#1112γ-Secretase substrates and methods of use
#1113DETECTION OF FRAGMENTS OF NECTIN-1 FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
#1114NEUROFURANS-INDICES OF OXIDANT STRESS
#1115Diagnostic agent
#1116Assay method for Alzheimer's disease
#1117Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
#1118Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling
#1119Anti-ADDL antibodies and uses thereof
#1120ANTIBODY HAVING INHIBITORY EFFECT ON AMYLOID FIBRIL FORMATION
#1121Human anti-amyloid beta peptide antibody and fragment of said antibody
#1122Naphthalene-based inhibitors of anti-apoptotic proteins
#1123Method of Screening for RAGE-Amyloid-Beta Peptide Interaction Inhibiting Materials
#1124USE OF A CAMELID SINGLE-DOMAIN ANTIBODY FOR DETECTING AN OLIGOMERIC FORM OF AN AMYLOID BETA PEPTIDE AND ITS APPLICATIONS
#1125PPM1E proteins and nucleic acids as targets for neurodegenerative diseases
#1126Antibody Specific Binding to A Beta Oligomer and the Use
#1127UTILIZATION OF NOVEL COMPOUNDS WITH AMYLOID AFFINITY AND METHOD OF PRODUCING THE SAME
#1128Methods for treating cone dystrophy with neuronal viability factor, RDCVF2
#1129MEASUREMENT OF NEURAL ACTIVITY
#1130Anti-ADDL monoclonal antibody and use thereof
#1131Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II
#1132Humanin receptor or humanin-like polypeptide receptor
#1133ASSAY FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE RATIO OF GAMMA-SECRETASE ABETA CLEAVAGE PRODUCTS
#1134USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME
#1135Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#1136Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#1137Antibodies specific for the protofibril form of beta-amyloid protein
#1138Structure-based design of peptide inhibitors of amyloid fibrillation
#1139Method of Screening Compounds Having Anti-Amyloid Properties
#1140GENETIC POLYMORPHISMS ASSOCIATED WITH ALZHEIMER'S DISEASE, METHODS OF DETECTION AND USES THEREOF
#1141Amyloid-β binding peptides
#1142Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof
#1143Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress
#1144Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum
#1145Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States
#1146DIAGNOSTIC METHOD BASED ON LARGE SCALE IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS
#1147BIOMARKERS FOR NEUROLOGICAL CONDITIONS
#1148DIAGNOSING NEURODEGENERATIVE DISEASES
#1149DISCORDANT HELIX STABILIZATION FOR PREVENTION OF AMYLOID FORMATION
#1150METHOD FOR THE DETECTION OF AMYLOID-B OLIGOMERS IN BODY FLUIDS
#1151COLLECTION OF BIOMARKERS FOR DIAGNOSIS AND MONITORING OF ALZHEIMER'S DISEASE IN BODY FLUIDS
#1152CELLS EXPRESSING ALPHA-SYNUCLEIN AND USES THEREFOR
#1153MODIFICATION OF AMYLOID-BETA LOAD IN NON-BRAIN TISSUE
#1154SOLUBLE LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN BINDS DIRECTLY TO ALZHEIMER'S AMYLOID-BETA PEPTIDE
#1155Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
#1156Methods of Identifying Disease Biomarkers in the Lense of the Eye
#1157Inhibitor for the formation of gamma-secretase complex
#1158Detection and/or Characterisation of Oligomers
#1159Truncated tau proteins
#1160Method for detecting aggregate-forming circulating protein forms using an agent for aggregating said forms and an agent for capturing formed aggregates
#1161In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders
#1162Biomarkers, kits, and method for diagnosing, monitoring, and/or staging Alzheimer's disease
#1163Oligopeptides for treatment of osteoporosis and other bone diseases and methods therefor
#1164USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#1165IRON-REGULATING PROTEIN-2(IRP-2) AS A DIAGNOSTIC FOR NEURODEGENERATIVE DISEASE
#1166Method for Identiflying Modulators of Rufy2 Useful for Treating Alzheimer's Disease
#1167IN VITRO METHOD FOR THE DIAGNOSIS AND EARLY DIAGNOSIS OF NEURODEGENERATIVE DISORDERS
#1168GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#1169Antibodies that specifically bind to Aβ oligomers and uses thereof
#1170METHOD OF DIAGNOSING A NEURODEGENERATIVE DISEASE
#1171RECEPTOR FOR AMYLOID BETA AND USES THEREOF
#1172Human brain carboxypeptidase B
#1173Diagnosis and Prediction of Alzheimer's Disease
#1174Stimulus-elicited genomic profile markers of alzheimer's disease
#1175Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides
#1176Molecular probe for sphingolipids
#1177Methods for the diagnosis of dementia and other neurological disorders
#1178Methods and Tools for The Therapy of Neurodegenerative Pathologies
#1179METHODS FOR THE DIAGNOSIS OF PROLIFERATIVE AND/OR CONFORMATIONAL DISEASES
#1180Modulators of alpha-synuclein toxicity
#1181PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#1182Method for Testing Alzheimer's Disease by Measuring Degradation Rate of B-Amyloid in Blood and Diagnostic Reagent
#1183PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#1184PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1185Anti-ADDLs antibodies and uses thereof
#1186Cell Model for Alzheimer's Disease Pathology
#1187Methods and compositions relating to alzheimer's disease
#1188ALZHEIMER'S DISEASE BIOMARKERS AND METHODS OF USE
#1189Detection of neurodegenerative disease
#1190Diagnostic Methods and Genetic Markers for Alzheimer Disease
#1191Amyloid beta receptor and uses thereof
#1192Protein isoforms and uses thereof
#1193Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
#1194METHODS AND COMPOSITIONS FOR DIAGNOSIS, STRATIFICATION, AND MONITORING OF ALZHEIMER'S DISEASE AND OTHER NEUROLOGICAL DISORDERS IN BODY FLUIDS
#1195Amyloid-beta globulomer antibodies
#1196COMPOSITIONS AND METHODS FOR INHIBITING GSK3 ACTIVITY AND USES THEREOF
#1197Drug development target protein and target gene, and method of screening
#1198Biomarkers and therapeutics targets for cognitive decline
#1199Saposin D and FAM3C are biomarkers for alzheimer's disease
#1200ALZHEIMER'S DISEASE ANIMAL MODEL, METHOD FOR OBTAINING SAME AND USES THEREOF